vimarsana.com

Page 10 - கேய்சிங்கேர் ஆரோக்கியம் அமைப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New service provided for diabetics, food insecure in Jersey Shore | News, Sports, Jobs

Briefcase | News, Sports, Jobs - Altoona Mirror

Virtual workshop set The Blair County Chamber of Commerce Safety Committee will host a virtual workshop from 8:30 to 9:30 a.m. April 23. The presentation, “One year of COVID What have we learned and where do we stand,” will be presented by Dr. Andrea Knab of Geisinger Health System-Mount Nittany Medical Center. Cost to attend is $10 for chamber members and $20 for nonmembers. To register, call the chamber at 814-943-8151 or go to www.blairchamber.com. LORETTO SFU sets free webinar The Saint Francis University Small Business Development Center and Bill Shipman of Swift Kennedy & Associates will host a free webinar on Employees Benefits and The New American Rescue Program at 11 a.m. April 22.

Liquid biopsies dominate FDA s latest breakthrough device nods

Share it Liquid biopsy developers feature heavily in the latest round of FDA breakthrough designations, with Natera, Inivata and Bluestar Genomics all securing the status for their blood-based cancer tests.  Natera disclosed two breakthrough designations for its Signatera molecular residual disease (MRD) test. The designations provide a boost to Natera’s efforts to develop the circulating tumor DNA test through phase 3 trials as a companion diagnostic to two cancer medicines.  Texas-based Natera framed the FDA designations, which bring the number of Signatera breakthrough statuses up to three, as a reflection of progress in its cancer biopharma business. The unit has signed $65 million in contracts over the past year. Natera is yet to win FDA approval but it performs the test as a CLIA-certified laboratory.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.